MicroVascular Tissues Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $4.11M

  • Investors
  • 1

MicroVascular Tissues General Information

Description

Developer of vascular products designed to address vascular deficiencies. The company specializes in stem cell research and human allograft tissue deployment services, providing researchers and physicians with products useful in biological vascular tissue implantation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Primary Office
  • 6199 Cornerstone Court East
  • Suite 109
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicroVascular Tissues Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 10-Mar-2023 $4.11M 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 12-Sep-2018 00.000 00.000 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 28-Aug-2014 $2.01M $2.01M 00.000 Completed Startup
To view MicroVascular Tissues’s complete valuation and funding history, request access »

MicroVascular Tissues Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 0.00
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 3,445,076 $0.001000 $1.15 $1.15 1x $1.15 24.96%
To view MicroVascular Tissues’s complete cap table history, request access »

MicroVascular Tissues Patents

MicroVascular Tissues Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3086408-A1 Compositions and methods for treating nerve injury Pending 08-Jan-2018 000000000
AU-2019205822-A1 Compositions and methods for treating nerve injury Inactive 08-Jan-2018 000000000
EP-3737355-A1 Compositions and methods for treating nerve injury Inactive 08-Jan-2018 000000000
US-20200353008-A1 Compositions and methods for treating nerve injury Pending 08-Jan-2018 000000000
EP-3737355-A4 Compositions and methods for treating nerve injury Inactive 08-Jan-2018 A61K9/0014 0
To view MicroVascular Tissues’s complete patent history, request access »

MicroVascular Tissues Executive Team (2)

Name Title Board Seat Contact Info
Glen Gong President, Chief Executive Officer & Board Member
Dale Peterson Ph.D Chief Technology Officer & Board Member
To view MicroVascular Tissues’s complete executive team members history, request access »

MicroVascular Tissues Board Members (2)

Name Representing Role Since
Dale Peterson Ph.D MicroVascular Tissues Chief Technology Officer & Board Member 000 0000
Kevin Oshasi Self Board Member 000 0000
To view MicroVascular Tissues’s complete board members history, request access »

MicroVascular Tissues Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Pond Capital Venture Capital Minority 000 0000 000000 0
To view MicroVascular Tissues’s complete investors history, request access »